BACKGROUND: The number of total hip arthroplasties (THA) being performed has been steadily increasing for decades. With increased primary THA surgical volume, revision THA numbers are also increasing at a steady pace. With the aging, increasingly comorbid patient populations and newly imposed financial penalties for hospitals with high readmission rates, refining understanding of factors influencing readmission following THA is a research priority. We hypothesize that numerous preoperative medical comorbidities and postoperative medical complications will emerge as significant positive risk factors for 30-day readmission. METHODS: ACS-NSQIP database identified patients who underwent revision THA from 2005 to 2015. The primary outcome assessed was hospital readmission within 30 days. Patient demographics, preoperative comorbidities, laboratory studies, operative characteristics, and postsurgical complications were compared between readmitted and non-readmitted patients. Logistic regression identified significant independent risk factors for 30-day readmission among these variables. RESULTS: 10,032 patients underwent revision THA in the ACS-NSQIP from 2005 to 2015; 855 (8.5%) were readmitted within 30-days. Increasing age, the presence of preoperative comorbidities, high ASA class, and increased operative time were significant positively associated independent risk factors for 30-day readmission. Several postoperative medical and surgical complications such as myocardial infarction, stroke, pneumonia, and sepsis demonstrated significant positive associations with readmission. CONCLUSION: Identifying and understanding risk factors associated with readmission allows for the implementation of evidence-based interventions aimed at minimizing risk and reducing 30-day readmission rates following revision THA.
BACKGROUND: The number of total hip arthroplasties (THA) being performed has been steadily increasing for decades. With increased primary THA surgical volume, revision THA numbers are also increasing at a steady pace. With the aging, increasingly comorbid patient populations and newly imposed financial penalties for hospitals with high readmission rates, refining understanding of factors influencing readmission following THA is a research priority. We hypothesize that numerous preoperative medical comorbidities and postoperative medical complications will emerge as significant positive risk factors for 30-day readmission. METHODS: ACS-NSQIP database identified patients who underwent revision THA from 2005 to 2015. The primary outcome assessed was hospital readmission within 30 days. Patient demographics, preoperative comorbidities, laboratory studies, operative characteristics, and postsurgical complications were compared between readmitted and non-readmitted patients. Logistic regression identified significant independent risk factors for 30-day readmission among these variables. RESULTS: 10,032 patients underwent revision THA in the ACS-NSQIP from 2005 to 2015; 855 (8.5%) were readmitted within 30-days. Increasing age, the presence of preoperative comorbidities, high ASA class, and increased operative time were significant positively associated independent risk factors for 30-day readmission. Several postoperative medical and surgical complications such as myocardial infarction, stroke, pneumonia, and sepsis demonstrated significant positive associations with readmission. CONCLUSION: Identifying and understanding risk factors associated with readmission allows for the implementation of evidence-based interventions aimed at minimizing risk and reducing 30-day readmission rates following revision THA.
Authors: Joseph A Bosco; Alexa J Karkenny; Lorraine H Hutzler; James D Slover; Richard Iorio Journal: J Arthroplasty Date: 2013-11-19 Impact factor: 4.757
Authors: Ryan P Merkow; Mila H Ju; Jeanette W Chung; Bruce L Hall; Mark E Cohen; Mark V Williams; Thomas C Tsai; Clifford Y Ko; Karl Y Bilimoria Journal: JAMA Date: 2015-02-03 Impact factor: 56.272
Authors: Carlos A Higuera; Karim Elsharkawy; Alison K Klika; Matthew Brocone; Wael K Barsoum Journal: Clin Orthop Relat Res Date: 2011-02-23 Impact factor: 4.176
Authors: Kevin J Bozic; Atul F Kamath; Kevin Ong; Edmund Lau; Steve Kurtz; Vanessa Chan; Thomas P Vail; Harry Rubash; Daniel J Berry Journal: Clin Orthop Relat Res Date: 2014-12-03 Impact factor: 4.176
Authors: Christopher J Dy; Kevin J Bozic; Ting Jung Pan; Timothy M Wright; Douglas E Padgett; Stephen Lyman Journal: Arthritis Care Res (Hoboken) Date: 2014-06 Impact factor: 4.794